1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Plant-based Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Plant-based Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Plant-based Vaccines Market Regional Analysis
6.2 Europe Plant-based Vaccines Market Revenue 2019-2028 (US$ Million)
6.3 Europe Plant-based Vaccines Market Forecast Analysis
7. Europe Plant-based Vaccines Market Analysis – by Vaccine Type
7.1 Bacterial Vaccines
- 7.1.1 Overview
- 7.1.2 Bacterial Vaccines: Europe Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Viral Vaccines
- 7.2.1 Overview
- 7.2.2 Viral Vaccines: Europe Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Parasite Vaccines
- 7.3.1 Overview
- 7.3.2 Parasite Vaccines: Europe Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Plant-based Vaccines Market Analysis – by Source
8.1 Tobacco Plant
- 8.1.1 Overview
- 8.1.2 Tobacco Plant: Europe Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Maize
- 8.2.1 Overview
- 8.2.2 Maize: Europe Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Potato
- 8.3.1 Overview
- 8.3.2 Potato: Europe Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Plant-based Vaccines Market Analysis – by Application
9.1 Influenza
- 9.1.1 Overview
- 9.1.2 Influenza: Europe Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Zika Virus
- 9.2.1 Overview
- 9.2.2 Zika Virus: Europe Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Ebola Virus
- 9.3.1 Overview
- 9.3.2 Ebola Virus: Europe Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Poultry Disease
- 9.4.1 Overview
- 9.4.2 Poultry Disease: Europe Plant-based Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe Plant-based Vaccines Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Plant-based Vaccines Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 Europe Plant-based Vaccines Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Plant-based Vaccines Market Breakdown, by Vaccine Type
- 10.2.1.1.2 UK: Europe Plant-based Vaccines Market Breakdown, by Source
- 10.2.1.1.3 UK: Europe Plant-based Vaccines Market Breakdown, by Application
- 10.2.1.2 Germany:
Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Plant-based Vaccines Market Breakdown, by Vaccine Type
- 10.2.1.2.2 Germany: Europe Plant-based Vaccines Market Breakdown, by Source
- 10.2.1.2.3 Germany: Europe Plant-based Vaccines Market Breakdown, by Application
- 10.2.1.3 France:
Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Plant-based Vaccines Market Breakdown, by Vaccine Type
- 10.2.1.3.2 France: Europe Plant-based Vaccines Market Breakdown, by Source
- 10.2.1.3.3 France: Europe Plant-based Vaccines Market Breakdown, by Application
- 10.2.1.4 Russia:
Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Plant-based Vaccines Market Breakdown, by Vaccine Type
- 10.2.1.4.2 Russia: Europe Plant-based Vaccines Market Breakdown, by Source
- 10.2.1.4.3 Russia: Europe Plant-based Vaccines Market Breakdown, by Application
- 10.2.1.5 Italy:
Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Plant-based Vaccines Market Breakdown, by Vaccine Type
- 10.2.1.5.2 Italy: Europe Plant-based Vaccines Market Breakdown, by Source
- 10.2.1.5.3 Italy: Europe Plant-based Vaccines Market Breakdown, by Application
- 10.2.1.6 Rest of Europe:
Europe Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Plant-based Vaccines Market Breakdown, by Vaccine Type
- 10.2.1.6.2 Rest of Europe: Europe Plant-based Vaccines Market Breakdown, by Source
- 10.2.1.6.3 Rest of Europe: Europe Plant-based Vaccines Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 British American Tobacco p.l.c.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Creative Biolabs, Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Leaf Expression Systems Ltd.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 LenioBio
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Lumen Bioscience, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 ZYUS Life Sciences Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For Europe Plant-based Vaccines Market
